HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement applauding the U.S. Food and Drug Administration (FDA) for releasing new data to help generic drug competitors:
Click here for the full statement.
Related Posts
HSCA Comments to the Senate HELP Committee on Planning for the Next Pandemic
June 29, 2020
Dear Chairman Alexander and Ranking Member Murray: On behalf of the...
HSCA Statement on House Committee on Homeland Security Hearing on the Coronavirus
March 11, 2020
Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
June 19, 2019
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA E&C Letter on Improving Competition in the Generic Marketplace
April 1, 2019
Dear Chairman Pallone and Ranking Member Walden, I am writing to you on behalf...